Aleafia Health & Emblem Merger Creates a New Cannabis Leader
March 21st, 2019
Exclusive, News, Top Story
Aleafia Health Inc. (TSX: ALEF) (OTCQB: ALEAF) (FRA: ARAH) recently announced the completion of its merger with Emblem Corp. Under the terms of the agreement, Aleafia Health acquired all of Emblem’s common shares and formed a new wholly-owned subsidiary that will keep the name Emblem name. The completion of the merger marks a key milestone for both companies as they work to build long-term shareholder value.
In this article, we will take a closer look at the implications of the merger and why investors may want to take a closer look at Aleafia Health following the transaction.
Creating a New Leader
Aleafia Health’s merger with Emblem creates Canada’s largest medical cannabis clinic with more than 60,000 patients with access to unique cannabis oils, capsules and sprays. In addition, the company’s three dedicated cultivation facilities provide an ample cannabis supply to provinces, retailers and export markets. These operations are already generating significant revenue under the largest LP-to-LP supply agreement in the industry.
“The acquisition of Emblem rapidly accelerates the execution of Aleafia Health’s strategy and positioning as a vertically-integrated, diversified cannabis company with an integrated, highly differentiated consumer ecosystem,” says Aleafia Health CEO Geoffrey Benic. “Emblem’s product leadership in the medical and adult-use sectors and highly coveted supply agreements will perfectly complement our cannabis production and clinic operations.”
During the third quarter of 2018, Emblem’s revenue grew 281 percent to $2.3 million with an industry-leading $10.67 of revenue per gram equivalent. The company also reported a 20 percent quarter-over-quarter increase in its patient population to over 4,800 active patients. On the product side, the company launched an innovative oral dose-metered spray, Atmosphere, and its first adult-use cannabis brand, Symbl.
Numerous Catalysts Ahead
Aleafia Health has been making tremendous progress on its own initiatives apart from the Emblem merger. During the third quarter of 2018, the company indicated that the fully-funded retrofitting of its 160,000 sq. ft. Niagara greenhouse facility and outdoor expansion was on schedule. Management anticipates that these efforts will result in an annual production capacity of 98,000 kilograms, making it one of the larger licensed producers in Canada.
In addition to improving production capacity, the company continues to invest in patient education as a key differentiator. The company has developed and implemented a proprietary training program for all of its staff to help those with chronic medical conditions that have failed first, second, and often, third line approaches. The training program extends to both internal and partner clinics to service a maximum amount of patients.
The company also continues to make waves in the medical cannabis research space. With more than 60,000 patients, the company has amassed one of the largest medical cannabis datasets in the world, enabling researchers to validate cannabis sciences, product teams to develop innovative new products, and management to build a strong IP portfolio. In the third quarter, this division contributed $612,000 to revenue.
Aleafia Health Inc. (TSX-V: ALEF) (OTCQB: ALEAF) (FRA: ARAH) is well positioned within Canada’s nascent cannabis industry following its merger with Emblem. With robust patient growth, high margin products, and growing revenue, investors may want to take a closer look at the combined company ahead of several potential catalysts.
For more information, visit the company’s website at www.aleafiahealth.com.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.